|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004048,
umls-concept:C0006142,
umls-concept:C0038317,
umls-concept:C0039082,
umls-concept:C0205421,
umls-concept:C0600688,
umls-concept:C1328050,
umls-concept:C1516213,
umls-concept:C1708528,
umls-concept:C1831743,
umls-concept:C2709248
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-6-12
|
|
pubmed:abstractText |
To evaluate the efficacy of inhaled fluticasone propionate (Flovent) as prophylaxis against delayed pulmonary toxicity syndrome (DPTS) and decline in pulmonary function in breast cancer patients undergoing high-dose chemotherapy with the conditioning regimen of cyclophosphamide, cisplatin, and carmustine (CPB) followed by autologous stem cell transplantation (ASCT).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1083-8791
|
|
pubmed:author |
pubmed-author:BroadwaterGG,
pubmed-author:ChauN PNP,
pubmed-author:FolzR FRF,
pubmed-author:LoftisJ SJS,
pubmed-author:LongG DGD,
pubmed-author:McDonaldCC,
pubmed-author:McGaugheyD SDS,
pubmed-author:MorrisA KAK,
pubmed-author:NikcevichD ADA,
pubmed-author:RizzieriDD,
pubmed-author:SmithC ACA,
pubmed-author:VredenburghJ JJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
274-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11400949-Administration, Inhalation,
pubmed-meshheading:11400949-Adult,
pubmed-meshheading:11400949-Aged,
pubmed-meshheading:11400949-Androstadienes,
pubmed-meshheading:11400949-Anti-Inflammatory Agents,
pubmed-meshheading:11400949-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11400949-Breast Neoplasms,
pubmed-meshheading:11400949-Cohort Studies,
pubmed-meshheading:11400949-Female,
pubmed-meshheading:11400949-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11400949-Humans,
pubmed-meshheading:11400949-Incidence,
pubmed-meshheading:11400949-Lung Diseases,
pubmed-meshheading:11400949-Middle Aged,
pubmed-meshheading:11400949-Respiratory Function Tests,
pubmed-meshheading:11400949-Steroids,
pubmed-meshheading:11400949-Syndrome,
pubmed-meshheading:11400949-Transplantation, Autologous,
pubmed-meshheading:11400949-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
|
|
pubmed:affiliation |
Adult Bone Marrow and Stem Cell Transplant Program, Duke University Medical Center, Durham, North Carolina 27710, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
